COVID-19 INFECTION AND THROMBOEMBOLIC RISK IN PATIENTS WITH CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION: ANALYSIS USING CHA₂DS₂-VASC AND HAS-BLED SCORES
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
The objective of this study was to evaluate thromboembolic risk of patients with chronic heart failure (CHF) and atrial fibrillation (AF) after exposure to COVID-19, utilizing CHA₂DS₂-VASc and HAS-BLED scoring systems. This was a retrospective cohort study in 260 subjects: the aged population was selected for the analysis if they had a clear diagnostic diagnosis of CHF and AF and were ≥60 years old at time of analysis. Patients were stratified into Post-COVID (n=130) and Non-COVID (n=130) categories. Clinical responses, thromboembolic events, major bleeding ep¬isodes and laboratory markers (including D-dimer) were assessed for 12 months in this study. The Post-COVID group had associated higher thromboembolic events, including pulmonary embolism (12.4%, p
Fields of Study & Subjects
Atrial Fibrillation Management and Outcomes
COVID-19 Clinical Research Studies
Venous Thromboembolism Diagnosis and Management
Publication details
- Journal / source
- CyberLeninK (CyberLeninka)
- Publication date
- 1 January 2026
- Language
- EN